Sinopsis
Featuring one-on-one interviews with clinical investigators discussing the most important oral presentations and posters presented at the significant scientific symposia, this series provides an overview of new clinical trial data and the impact it has on current cancer management.
Episodios
-
For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
27/06/2025 Duración: 01h26minDr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia. NCPD information and select publications here.
-
Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
25/06/2025 Duración: 01h56minDr Neeraj Agarwal from the University of Utah Huntsman Cancer Institute in Salt Lake City, Dr Andrew J Armstrong from Duke Cancer Institute in Durham, North Carolina, Dr Himisha Beltran from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Fred Saad from the University of Montreal Hospital Center in Québec, Canada, and Dr Rana R McKay from the UC San Diego Moores Cancer Center discuss recent updates on available and novel treatment strategies for prostate cancer. CME information and select publications here.
-
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
24/06/2025 Duración: 01h29minMs Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. NCPD information and select publications here.
-
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
23/06/2025 Duración: 54minDr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas. CME information and select publications here.
-
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
20/06/2025 Duración: 01h57minProf Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual meeting. CME information and select publications here.
-
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases
18/06/2025 Duración: 01h01minDr Geoffrey Y Ku from the Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Zev Wainberg from the UCLA School of Medicine discuss patient cases and summarize current treatment approaches for gastroesophageal cancer. CME information and select publications here.
-
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
17/06/2025 Duración: 59minProf Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas MD Anderson Cancer Center in Houston, Texas, provide their perspectives on relevant new clinical data in multiple myeloma and their application to disease treatment. CME information and select publications here.
-
For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress
16/06/2025 Duración: 01h54minDrs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein. NCPD information and select publications here.
-
For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress
12/06/2025 Duración: 01h29minDr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. NCPD information and select publications here.
-
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
11/06/2025 Duración: 59minProfessor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment. CME information and select publications here.
-
Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances
09/06/2025 Duración: 58minDr Jessica J Lin from Massachusetts General Hospital in Boston and Dr Joel W Neal from Stanford Cancer Institute in California summarize major treatment advances over the past year and review relevant ongoing clinical trials using targeted therapies for patients with non-small cell lung cancer. CME information and select publications here.
-
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
06/06/2025 Duración: 01h28minDr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.
-
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
05/06/2025 Duración: 59minDr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma. CME information and select publications here.
-
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
04/06/2025 Duración: 01h01minDr Ian Krop from Yale Cancer Center in New Haven, Connecticut, and Dr Sara Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with breast cancer. CME information and select publications here.
-
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
03/06/2025 Duración: 01h22minDr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer. CME information and select publications here.
-
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
02/06/2025 Duración: 47minClinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. CME information and select publications here.
-
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit
01/06/2025 Duración: 51minClinical investigators discuss available data guiding the management of hepatocellular carcinoma. CME information and select publications here.
-
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
31/05/2025 Duración: 50minClinical investigators discuss available data guiding the management of multiple myeloma. CME information and select publications here.
-
Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
30/05/2025 Duración: 01h33minDrs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. CME information and select publications here.
-
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
28/05/2025 Duración: 50minDr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.